Author Question: Even with today's advances in technology, computing power is still a barrier to completing a ... (Read 52 times)

tsand2

  • Hero Member
  • *****
  • Posts: 520
Even with today's advances in technology, computing power is still a barrier to completing a research project.
 
 Indicate whether the statement is true or false

Question 2

Which of the following is not a characteristic of radio?
 a. high reach c. focused targeting
  b. high cost per exposure d. room for creativity



nyrave

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

F
Today, computing power is seldom a barrier to completing a research project.

Answer to Question 2

B
Due to its high reach, radio provides low cost per exposure.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

There used to be a metric calendar, as well as metric clocks. The metric calendar, or "French Republican Calendar" divided the year into 12 months, but each month was divided into three 10-day weeks. Each day had 10 decimal hours. Each hour had 100 decimal minutes. Due to lack of popularity, the metric clocks and calendars were ended in 1795, three years after they had been first marketed.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library